Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT00094133
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* History of primary breast cancer
* No evidence of detectable disease
* At least 14 hot flashes per week for ≥ 1 month by self-reporting
* Hormone receptor status not specified
PATIENT CHARACTERISTICS:
* Female
* Life expectancy \> 6 months
* Menopausal status not specified
* Outpatient status
* No medical or psychiatric condition that would preclude study participation
PRIOR CONCURRENT THERAPY:
* Concurrent antihormonal agents for breast cancer (e.g., tamoxifen or raloxifene) allowed provided the patient has been on them for ≥ 1 month
* No other concurrent hormonal therapy
* No other putative therapies for hot flashes ≥ 1 month prior to study entry
* Concurrent vitamin E allowed
* No other concurrent treatment for hot flashes
* No concurrent cytotoxic chemotherapy
* Not concurrently using hypnosis for any reason
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00094133
Study Brief:
Protocol Section:
NCT00094133